We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $1.26B
1-Year Est. Return 95.39%
This Fund
S&P 500
This Quarter Est. Return
+13.08%
1 Year Est. Return
+95.39%
3 Year Est. Return
+360.87%
5 Year Est. Return
+519.82%
10 Year Est. Return
+3,025.56%
AUM
$556M
AUM Growth
+$3.81M
Cap. Flow
-$16.7M
Cap. Flow %
-3.01%
Top 10 Hldgs %
18.75%
Holding
334
New
59
Increased
88
Reduced
117
Closed
54

Top Buys

Rank Stock Value
1
TECH icon
Bio-Techne
TECH
+$7.5M
2
PYPL icon
PayPal
PYPL
+$7.37M
3
LFUS icon
Littelfuse
LFUS
+$6.9M
4
ENTG icon
Entegris
ENTG
+$6.86M
5
AMED
Amedisys
AMED
+$6.85M

Top Sells

Rank Stock Value
1
VRSK icon
Verisk Analytics
VRSK
+$12.2M
2
PAYC icon
Paycom
PAYC
+$8.46M
3
ZTS icon
Zoetis
ZTS
+$7.77M
4
V icon
Visa
V
+$7.46M
5
BALL icon
Ball Corp
BALL
+$7.15M

Sector Composition

Rank Sector Weight
1 Technology 33.34%
2 Healthcare 14.27%
3 Consumer Discretionary 11.88%
4 Industrials 8.92%
5 Consumer Staples 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDP
326
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
-9,715
Closed -$258K
VCRA
327
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
-13,481
Closed -$560K
MXIM
328
DELISTED
Maxim Integrated Products
MXIM
-29,377
Closed -$2.6M
CLCT
329
DELISTED
Collectors Universe
CLCT
-3,969
Closed -$299K
SVA
330
DELISTED
Sinovac Biotech, Ltd
SVA
$0 ﹤0.01%
22,248

Similar funds

Navellier & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Navellier & Associates held 334 positions worth $556M, up 0.69% from $552M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Navellier & Associates withdrew a net $16.7M in Q1 2021, closing 54 positions and reducing 117 holdings. Its most notable exit was Verisk Analytics, an estimated $12.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Navellier & Associates opened a new position in Bio-Techne worth $7.85M.

  • Navellier & Associates's largest Q1 2021 buy was Bio-Techne: 82,224 shares worth $7.85M.
  • Navellier & Associates added most to PayPal in Q1 2021, an estimated $7.37M increase.
  • Navellier & Associates's biggest Q1 2021 reduction was Paycom, cutting an estimated $8.46M.
  • Navellier & Associates fully exited Verisk Analytics in Q1 2021, selling an estimated $12.2M.
  • Navellier & Associates's ten largest holdings make up 19% of its $556M portfolio in Q1 2021.
  • Navellier & Associates opened 59 new positions and closed 54 in Q1 2021.
  • Navellier & Associates's portfolio value rose 0.69% quarter-over-quarter to $556M.

Based on Navellier & Associates's 13F filing for Q1 2021, filed 12 May 2021.